You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-PDCD4 antibody (ab51495)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab51495? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab51495 has been referenced in 5 publications.

  1. Deftereos G et al. Expression of Mir-21 and Mir-143 in Cervical Specimens Ranging from Histologically Normal through to Invasive Cervical Cancer. PLoS One 6:e28423 (2011). IHC-P. PubMed: 22194833
  2. Haraguchi T et al. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res 37:e43 (2009). WB. PubMed: 19223327
  3. Yamamichi N et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 15:4009-16 (2009). IHC-P; Human. PubMed: 19509156
  4. Qi L et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 9:163 (2009). IHC-P; Human. PubMed: 19473551
  5. Ohno M et al. The modulation of MicroRNAs by type I IFN through the activation of signal transducers and activators of transcription 3 in human glioma. Mol Cancer Res 7:2022-30 (2009). PubMed: 19934272

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"